Related Experiment Videos
Platelet monoamine oxidase activity in schizophrenia
The American Journal of Psychiatry
|October 1, 1976
Summary
Platelet monoamine oxidase activity did not significantly differ between chronic schizophrenic patients and healthy individuals. Careful laboratory techniques are crucial for accurate results in schizophrenia research.
Area of Science:
- Neuroscience
- Biochemistry
- Psychiatry
Background:
- Platelet monoamine oxidase (MAO) is an enzyme involved in neurotransmitter metabolism.
- Altered MAO activity has been investigated as a potential biomarker in psychiatric disorders, including schizophrenia.
Purpose of the Study:
- To investigate the activity of platelet monoamine oxidase (MAO) in patients with chronic schizophrenia.
- To compare MAO activity in schizophrenic patients with that of a matched control group.
Main Methods:
- Blood samples were collected from 12 chronic schizophrenic patients and a matched group of normal individuals.
- Platelet monoamine oxidase activity was measured using standardized biochemical assays.
- Emphasis was placed on simultaneous processing of control and patient samples to minimize procedural variability.
Main Results:
- No significant difference was found in platelet monoamine oxidase activity between the chronic schizophrenic patients and the normal individuals.
- The study highlighted the sensitivity of MAO assays to procedural variations.
Conclusions:
- Platelet monoamine oxidase activity may not be a reliable indicator for differentiating chronic schizophrenia from healthy controls.
- Strict adherence to controlled laboratory techniques, including simultaneous sample processing and minimizing leucocyte contamination, is essential for reproducible and valid results in platelet enzyme studies.